Hans Törnblom

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 37

Top Topics

Irritable Bowel Syndrome

Medical Education

Top Venues

Alimentary pharmacology & therapeutics

United European gastroenterology journal

Neurogastroenterology and motility

Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society

This page only lists publications with an associated author ORCID identifier.

Publications

Jenny Lövdahl, Hans Törnblom
Editorial: Can we predict or not predict response to hypnotherapy? That is the question. Alimentary pharmacology & therapeutics 59 (3) (2024)
Arta Aliu, Daan H C A Bosch, Daniel Keszthelyi, Ashkan Rezazadeh Ardabili, Jean Frederic Colombel, Rachel Sawyer, Hans Törnblom, Ailsa L Hart, Daisy M A E Jonkers, Marieke J Pierik, Zlatan Mujagic
Letter: Intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in IBD-Authors' reply. Alimentary pharmacology & therapeutics 59 (12) (2024)
Arta Aliu, Daan H C A Bosch, Daniel Keszthelyi, Ashkan Rezazadeh Ardabili, Jean Frederic Colombel, Rachel Sawyer, Hans Törnblom, Ailsa L Hart, Daisy M A E Jonkers, Marieke J Pierik, Zlatan Mujagic
Review article: A practical approach to persistent gastrointestinal symptoms in inflammatory bowel disease in remission. Alimentary pharmacology & therapeutics (2024)
Arta Aliu, Daan H C A Bosch, Daniel Keszthelyi, Ashkan Rezazadeh Ardabili, Jean Frederic Colombel, Rachel Sawyer, Hans Törnblom, Ailsa L Hart, Daisy M A E Jonkers, Marieke J Pierik, Zlatan Mujagic
Letter: Intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in IBD-Authors' reply. Alimentary pharmacology & therapeutics 59 (12) (2024)
Cristina Iribarren, Otto Savolainen, Maria Sapnara, Hans Törnblom, Magnus Simrén, Maria K Magnusson, Lena Öhman
Temporal stability of fecal metabolomic profiles in irritable bowel syndrome. Neurogastroenterology and motility 36 (3) (2024)
Arta Aliu, Daan H C A Bosch, Daniel Keszthelyi, Ashkan Rezazadeh Ardabili, Jean Frederic Colombel, Rachel Sawyer, Hans Törnblom, Ailsa L Hart, Daisy M A E Jonkers, Marieke J Pierik, Zlatan Mujagic
Letter: Intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in IBD-Authors' reply. Alimentary pharmacology & therapeutics (2024)
Cristina Iribarren, Otto Savolainen, Maria Sapnara, Hans Törnblom, Magnus Simrén, Maria K Magnusson, Lena Öhman
Temporal stability of fecal metabolomic profiles in irritable bowel syndrome. Neurogastroenterology and motility (2024)
Arta Aliu, Daan H C A Bosch, Daniel Keszthelyi, Ashkan Rezazadeh Ardabili, Jean Frederic Colombel, Rachel Sawyer, Hans Törnblom, Ailsa L Hart, Daisy M A E Jonkers, Marieke J Pierik, Zlatan Mujagic
Review article: A practical approach to persistent gastrointestinal symptoms in inflammatory bowel disease in remission. Alimentary pharmacology & therapeutics 59 (12) (2024)
Jenny Lövdahl, Hans Törnblom
Editorial: Can we predict or not predict response to hypnotherapy? That is the question. Alimentary pharmacology & therapeutics 59 (3) (2024)
Arta Aliu, Daan H C A Bosch, Daniel Keszthelyi, Ashkan Rezazadeh Ardabili, Jean Frederic Colombel, Rachel Sawyer, Hans Törnblom, Ailsa L Hart, Daisy M A E Jonkers, Marieke J Pierik, Zlatan Mujagic
Review article: A practical approach to persistent gastrointestinal symptoms in inflammatory bowel disease in remission. Alimentary pharmacology & therapeutics 59 (12) (2024)
Arta Aliu, Daan H C A Bosch, Daniel Keszthelyi, Ashkan Rezazadeh Ardabili, Jean Frederic Colombel, Rachel Sawyer, Hans Törnblom, Ailsa L Hart, Daisy M A E Jonkers, Marieke J Pierik, Zlatan Mujagic
Review article: A practical approach to persistent gastrointestinal symptoms in inflammatory bowel disease in remission. Alimentary pharmacology & therapeutics 59 (12) (2024)
Tom van Gils, Jóhann Páll Hreinsson, Hans Törnblom, Tack Jan, Shrikant Ishver Bangdiwala, Olafur S Palsson, Ami D Sperber, Magnus Simrén
Symptom profiles compatible with disorders of gut-brain interaction (DGBI) in organic gastrointestinal diseases: A global population-based study. United European gastroenterology journal (2024)
Cristina Iribarren, Otto Savolainen, Maria Sapnara, Hans Törnblom, Magnus Simrén, Maria K Magnusson, Lena Öhman
Temporal stability of fecal metabolomic profiles in irritable bowel syndrome. Neurogastroenterology and motility 36 (3) (2024)
Axel Josefsson, Magnus Simrén, Adam Smolak, Nour Sabbagh, Hans Törnblom
Natural history of symptoms and prognostic information of the rapid drink challenge and solid bolus swallows in esophagogastric junction outflow obstruction defined by manometry. Neurogastroenterology and motility (2023)
Navkiran Thind Tornkvist, Magnus Simrén, Jóhann Páll Hreinsson, Jan Tack, Shrikant I Bangdiwala, Ami D Sperber, Olafur S Palsson, Axel Josefsson, Hans Törnblom
Prevalence and impact of disorders of Gut-Brain interaction in Sweden. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2023)
Hans Törnblom
Gastric emptying rate and relevance for symptoms. United European gastroenterology journal (2023)
Inês A Trindade, Jóhann Páll Hreinsson, Chloé Melchior, Joost P Algera, Esther Colomier, Hans Törnblom, Douglas Drossman, Tack Jan, Olafur S Palsson, Shrikant I Bangdiwala, Ami D Sperber, Magnus Simrén
Global prevalence of psychological distress and comorbidity with disorders of gut-brain interactions. The American journal of gastroenterology (2023)
Åsa Frändemark, Hans Törnblom, Jóhann Páll Hreinsson, Viola Andresen, Marc A Benninga, Enrico S Corazziari, Shin Fukudo, Agata Mulak, Javier Santos, Ami D Sperber, Shrikant I Bangdiwala, Olafur S Palsson, Magnus Simrén
Work productivity and activity impairment in disorders of gut-brain interaction: Data from the Rome Foundation Global Epidemiology Study. United European gastroenterology journal (2023)
Kyle D Staller, Ola Olén, Jonas Söderling, Bjorn Roelstraete, Hans Törnblom, Braden Kuo, Long H Nguyen, Jonas F Ludvigsson
Antibiotic use as a risk factor for irritable bowel syndrome: Results from a nationwide, case-control study. Alimentary pharmacology & therapeutics (2023)
Joost P Algera, Maria K Magnusson, Lena Öhman, Stine Störsrud, Magnus Simrén, Hans Törnblom
Editorial: gluten-free but not pain-free in IBS-authors' reply. Alimentary pharmacology & therapeutics 56 (11-12) (2022)
I-Hsuan Huang, Jolien Schol, Rutaba Khatun, Florencia Carbone, Karen Van den Houte, Esther Colomier, Lukas Michaja Balsiger, Hans Törnblom, Tim Vanuytsel, Elias Sundelin, Magnus Simrén, Olafur S Palsson, Shrikant I Bangdiwala, Ami D Sperber, Tack Jan
Worldwide prevalence and burden of gastroparesis-like symptoms as defined by the United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis. United European gastroenterology journal 10 (8) (2022)
Sanna Nybacka, Hans Törnblom, Magnus Simrén, Stine Störsrud
The Role of Carbohydrates in Irritable Bowel Syndrome: Protocol for a Randomized Controlled Trial Comparing Three Different Treatment Options. JMIR research protocols 11 (1) (2022)
Hans Törnblom
Editorial: rectal hyposensitivity in patients with hypermobile Ehlers-Danlos syndrome and constipation. Alimentary pharmacology & therapeutics 56 (5) (2022)
Jenny Lövdahl, Hans Törnblom, Gisela Ringstrom, Olafur S Palsson, Magnus Simrén
Editorial: group-based hypnotherapy as good as individually delivered hypnotherapy for symptoms of irritable bowel syndrome-authors' reply. Alimentary pharmacology & therapeutics 56 (1) (2022)
Jenny Lövdahl, Hans Törnblom, Gisela Ringström, Olafur S Palsson, Magnus Simrén
Randomised clinical trial: individual versus group hypnotherapy for irritable bowel syndrome. Alimentary pharmacology & therapeutics 55 (12) (2022)
Navkiran Thind Tornkvist, Hans Törnblom
European guidelines on functional bowel disorders with diarrhoea: United European Gastroenterology (UEG) and European Society for neurogastroenterology and motility (ESNM) statements and recommendations. United European gastroenterology journal 10 (7) (2022)
Hans Törnblom
Editorial: cannabis use disorders at the emergency department, a sign of a growing cannabinoid emergency. Alimentary pharmacology & therapeutics 57 (1) (2022)
Hans Törnblom
Editorial: cannabis use disorders at the emergency department, a sign of a growing cannabinoid emergency. Alimentary pharmacology & therapeutics 57 (1) (2022)
Chloé Melchior, Esther Colomier, Inês A Trindade, Mahrukh Khadija, Jóhann Páll Hreinsson, Hans Törnblom, Magnus Simrén
Irritable bowel syndrome: Factors of importance for disease-specific quality of life. United European gastroenterology journal 10 (7) (2022)
Joost P Algera, Maria K Magnusson, Lena Öhman, Stine Störsrud, Magnus Simrén, Hans Törnblom
Randomised controlled trial: effects of gluten-free diet on symptoms and the gut microenvironment in irritable bowel syndrome. Alimentary pharmacology & therapeutics 56 (9) (2022)
Valeria Castro Tejera, Lena Öhman, Lars Aabakken, Bengt Fellström, Trygve Hausken, Øistein Hovde, Johann P Hreinsson, Greger Lindberg, Per Venge, Magnus Simrén, Hans Törnblom
Randomised clinical trial and meta-analysis: mesalazine treatment in irritable bowel syndrome-effects on gastrointestinal symptoms and rectal biomarkers of immune activity. Alimentary pharmacology & therapeutics 56 (6) (2022)
Patrizia Burra, Marianna Arvanitakis, Jorge Amil Dias, Michael Bretthauer, Ana Dugic, Daniel Hartmann, Patrick Michl, Thomas Seufferlein, Joana Torres, Hans Törnblom, Monique E van Leerdam, Shira Zelber-Sagi, Andreea Botos
UEG position paper: Obesity and digestive health. United European gastroenterology journal (2022)
Joost P Algera, Esther Colomier, Chloé Melchior, Jóhann Páll Hreinsson, Irina Midenfjord, Egbert Clevers, Magnus Simrén, Hans Törnblom
Associations between postprandial symptoms, hydrogen and methane production, and transit time in irritable bowel syndrome. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2022)
Julia Simons, Umair Shajee, Olafur Palsson, Magnus Simren, Ami D Sperber, Hans Törnblom, William Whitehead, Imran Aziz
Disorders of gut-brain interaction: Highly prevalent and burdensome yet under-taught within medical education. United European gastroenterology journal 10 (7) (2022)
Hans Törnblom
Editorial: cannabis use disorders at the emergency department, a sign of a growing cannabinoid emergency. Alimentary pharmacology & therapeutics 57 (1) (2022)
Lena Böhn, Hans Törnblom, Lukas Van Oudenhove, Magnus Simrén, Stine Störsrud
A randomized double-blind placebo-controlled crossover pilot study: Acute effects of the enzyme α-galactosidase on gastrointestinal symptoms in irritable bowel syndrome patients. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 33 (7) (2021)
Sean M P Bennet, Johanna Sundin, Maria K Magnusson, Hans Strid, Julien Tap, Muriel Derrien, Boris Le Nevé, Joël Doré, Hans Törnblom, Magnus Simrén, Lena Öhman
Altered intestinal antibacterial gene expression response profile in irritable bowel syndrome is linked to bacterial composition and immune activation. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 30 (12) (2018)